ORIC

ORIC is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 51-200

Detailed ORIC Information

Geographic Data

ORIC headquarters map

Address: 240 East Grand Avenue

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

series d

Raised Last:

$55M

Raised Total:

$173M

Metrics

2,126,202Website Global Rank

9,294Website Monthly Traffic

Twitter Followers

Description

ORIC is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer.

Contact Phone:
+16503885600

Contact Email:

ORIC went public on 4/24/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/24/2020

IPO Valuation:
$459M

Ticker Symbol:
ORIC

IPO Price:
$16/share

Amount Raised:
$120M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2020 IPO $120M
12/2022 Post-IPO Equity $0 Pfizer
Pfizer
10/2014 Series A $15M Kravis Investment Partners
The Column Group
11/2014 Series A 1 $15M The Column Group
The Column Group
2/2018 Series C 11 $50M Memorial Sloan - Kettering Cancer Center
Fidelity Management and Research Company
Trinitas Capital
Topspin Fund
The Column Group
Taiho Ventures
OrbiMed
NS Investment
Kravis Investment Partners
Foresite Capital
Fidelity Management and Research Company
12/2015 Series B 6 $53M The Column Group
Topspin Partners
OrbiMed
Kohlberg Kravis Roberts
Foresite Capital
EcoR1 Capital
The Column Group
6/2023 Post-IPO Equity $0 Boxer Capital
EcoR1 Capital
Frazier Life Sciences
Nextech Invest
Venrock Healthcare Capital Partners
Boxer Capital
EcoR1 Capital
Frazier Life Sciences
Nextech Invest
Venrock Healthcare Capital Partners
Boxer Capital
EcoR1 Capital
Frazier Life Sciences
Nextech Invest
Venrock Healthcare Capital Partners
Boxer Capital
EcoR1 Capital
Frazier Life Sciences
Nextech Invest
Venrock Healthcare Capital Partners
8/2019 Series D $0 Memorial Sloan - Kettering Cancer Center
Taiho Ventures
Casdin Capital
Correlation Ventures
Invus
Irving Investors
OrbiMed
Hartford HealthCare Endowment
City Hill Ventures
Topspin Partners
ArrowMark Partners
Invus
The Column Group
Kravis Investment Partners
Foresite Capital
Memorial Sloan - Kettering Cancer Center
Taiho Ventures
Casdin Capital
Correlation Ventures
Invus
Irving Investors
OrbiMed
Hartford HealthCare Endowment
City Hill Ventures
Topspin Partners
ArrowMark Partners
Invus
The Column Group
Kravis Investment Partners
Foresite Capital
8/2019 Series D 16 $55M Arrowmark Partners
Invus Opportunities
Casdin Capital
The Column Group
TopSpin Partners
OrbiMed
EcoR1 Capital
Fidelity Management & Research Company
City Hill Ventures
Memorial Sloan Kettering Cancer Center
Foresite Capital
Taiho Ventures
Taiho Ventures
Casdin Capital
Correlation Ventures
Invus
Irving Investors
Memorial Sloan - Kettering Cancer Center
OrbiMed
Hartford HealthCare Endowment
City Hill Ventures
Topspin Partners
ArrowMark Partners
Invus
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research